Utah launches first in nation pilot for autonomous artificial intelligence prescription renewals
Utah launches first in nation pilot for autonomous artificial intelligence prescription renewals Utah has launched a 12 month pilot program...
PrescriberPoint AI agent automates prior authorization with 94.5% acceptance
PrescriberPoint artificial intelligence agent streamlines prior authorization workflow PrescriberPoint announced on April 21, 2026 that it is rolling out an...
2MM: AI Roundup – PrescriberPoint launches autonomous agent for prior authorization, Utah begins first in nation autonomous AI prescribing pilot, and JAMA study confirms ambient AI scribes return hours to the clinician work week
PrescriberPoint artificial intelligence agent streamlines prior authorization workflow PrescriberPoint shared on April 21, 2026 that it is rolling out an...
Orforglipron (Foundayo) expands oral treatment options for weight management
1. Orforglipron (Foundayo) introduces a new oral glucagon-like peptide-1 (GLP-1) receptor agonist that can be taken without food or timing...
Glucagon-like peptide-1 receptor agonists show potential in reducing substance use disorders
1. Glucagon-like peptide-1 (GLP-1) receptor agonists are associated with a lower risk of developing new substance use disorders. 2. These...
Sparsentan (Filspari) becomes first approved treatment for focal segmental glomerulosclerosis
1. Sparsentan (Filspari) becomes the first approved treatment specifically for focal segmental glomerulosclerosis. 2. Clinical trial data show meaningful reductions...
New targeted therapy daraxonrasib improves survival in pancreatic cancer
1. Daraxonrasib significantly improves survival in metastatic pancreatic cancer compared with standard chemotherapy. 2. Strong response rates in combination therapy...
Global medicine supply chains face mounting pressure amid Strait of Hormuz disruptions
1. Shipping slowdowns in the Strait of Hormuz are disrupting the movement of key pharmaceutical ingredients and finished generic drugs....
![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-350x250.png)
2 Minute Medicine: Pharma Roundup – Geopolitical instability in the Strait of Hormuz threatens global generic drug supply, daraxonrasib improves pancreatic cancer survival, sparsentan (Filspari) approved for focal segmental glomerulosclerosis, glucagon-like peptide-1 receptor agonists linked to reduced substance use disorders, and orforglipron (Foundayo) expands oral weight loss therapy options
Geopolitical instability in the Strait of Hormuz threatens global generic drug supply Ongoing escalations in the Strait of Hormuz have...
WHO launches 2026 global initiative to bridge the schizophrenia mortality gap
1. The World Health Organization has launched a global initiative to reduce the 15-to-20-year mortality gap for individuals with schizophrenia...
